- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Annexon Inc (ANNX)
Annexon Inc stock price live, this page displays NASDAQ ANNX stock exchange data. View the ANNX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Annexon Inc real time stock price chart below.
What Is the Annexon Inc Stock Price Today?
The Annexon Inc stock price today is 4.990.
What Is the Stock Symbol for Annexon Inc?
The stock symbol for Annexon Inc is "ANNX."
What Stock Exchange Does Annexon Inc Trade On?
Annexon Inc is listed and trades on the NASDAQ stock exchange.
Is Annexon Inc a Good Stock to Buy?
Determining whether Annexon Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANNX quote. (ISIN: US03589W1027)
What Is the Annexon Inc Stock Price Today?
The Annexon Inc stock price today is 4.990.
What Is the Stock Symbol for Annexon Inc?
The stock symbol for Annexon Inc is "ANNX."
What Stock Exchange Does Annexon Inc Trade On?
Annexon Inc is listed and trades on the NASDAQ stock exchange.
Is Annexon Inc a Good Stock to Buy?
Determining whether Annexon Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANNX quote. (ISIN: US03589W1027)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.955
5.175
52 wk Range
2.030
7.180
ANNX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.9555.175
52 wk Range
2.0307.180
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANNX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
14.714
Upside
+194.88%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Form 8K Annexon Inc For: 12 August- Investing.com
Annexon Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Annexon Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Why is Annexon stock sliding today?- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
8 Buy
2 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 14.714
(+194.88% Upside)
Annexon Inc Earnings Call Summary for Q2/2026
- Annexon posted Q2 loss of $0.28/share, missing consensus by $0.04 (16.67%); shares fell 6.37% premarket to $5.00 on the earnings miss.
- Company secured $200M credit facility with Oxford Finance, extending cash runway into 2028 despite zero product revenue and ongoing burn.
- ARCHER II geographic atrophy trial expanded with 24-month endpoint added to original 15-month target; enrollment reached 659 patients with 95% dosing compliance.
- Tanruprubart showed rapid improvement in Guillain-Barré syndrome FORWARD study; management advancing toward FDA biologics license application submission.
- CEO cited 'pivotal period' ahead as company positions as first to conduct randomized placebo-controlled GBS trials, targeting regulatory catalysts over near-term earnings.
Last Updated: 08/12/2026, 08:52 PM
Read Full TranscriptEarnings
Latest Release
Aug 12, 2026
EPS / Forecast
-0.28 / -0.24
Revenue / Forecast
-- / --
Compare ANNX to Peers and Sector
Metrics to compare | ANNX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANNXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.7x | −9.2x | −0.4x | |
PEG Ratio | −0.41 | −0.15 | 0.00 | |
Price/Book | 5.1x | 3.7x | 2.6x | |
Price / LTM Sales | - | 151.5x | 3.0x | |
Upside (Analyst Target) | 137.6% | 166.7% | 46.9% | |
Fair Value Upside | Unlock | −19.6% | 5.3% | Unlock |
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington’s disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. It is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Annexon (ANNX) Stock Price Today?
The Annexon stock price today is 4.990 USD.
What Stock Exchange Does Annexon Trade On?
Annexon is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Annexon?
The stock symbol for Annexon is "ANNX."
What Is the Annexon Market Cap?
As of today, Annexon market cap is 976.330M USD.
What Is Annexon's Earnings Per Share (TTM)?
The Annexon EPS (TTM) is -1.127.
When Is the Next Annexon Earnings Date?
Annexon will release its next earnings report on Nov 16, 2026.
From a Technical Analysis Perspective, Is ANNX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Annexon Stock Split?
Annexon has split 0 times.
How Many Employees Does Annexon Have?
Annexon has 92 employees.
What is the current trading status of Annexon (ANNX)?
As of Aug 26, 2026, Annexon (ANNX) is trading at a price of 4.990 USD, with a previous close of 5.150 USD. The stock has fluctuated within a day range of 4.955 USD to 5.175 USD, while its 52-week range spans from 2.030 USD to 7.180 USD.
What Is Annexon (ANNX) Price Target According to Analysts?
The average 12-month price target for Annexon is 14.714 USD, with a high estimate of 27 USD and a low estimate of 7 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +194.88% Upside potential.
What Is the ANNX Premarket Price?
ANNX's last pre-market stock price is 5.100 USD. The pre-market share volume is 11,900.000, and the stock has decreased by -0.050, or -0.970%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.